Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines
We appreciate the comments from Law and associates regarding our Perspective. They reiterate that pharmacokinetics (PK) of hydroxychloroquine (HCQ) are variable and that a daily dose produces variable blood concentrations depending on genetic factors, absorption variables, and effects of induction and inhibition of metabolizing enzymes, all topics that we reviewed in a previous publication.1
Source: American Journal of Ophthalmology - Category: Opthalmology Authors: David J. Browning, Naoto Yokogawa, Paul B. Greenberg, Elliot Perlman Tags: Correspondence Source Type: research